Holmium laser enucleation versus open prostatectomy for large volume benign prostatic hyperplasia: a meta-analysis of the therapeutic effect and safety.
- Author:
Hui CHEN
1
;
Ping TANG
;
Rubiao OU
;
Xiangrong DENG
;
Keji XIE
Author Information
- Publication Type:Journal Article
- MeSH: Humans; Lasers, Solid-State; adverse effects; Male; Prostatectomy; adverse effects; methods; Prostatic Hyperplasia; surgery; Randomized Controlled Trials as Topic
- From: Journal of Southern Medical University 2012;32(6):882-885
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo compare holmium laser enucleation (HoLEP) versus open prostatectomy (OP) for large volume benign prostatic hyperplasia.
METHODSThe randomized controlled trials (RCTs) pertaining to HoLEP and OP for management of large volume benign prostatic hyperplasia were retrieved from Medline and Embase. Meta-analysis was performed using Review Manager 5.0 software.
RESULTSThree RCTs were included in the analysis. No significant differences were found in IPSS or Qmax between HoLEP and OP (P>0.05). Compared with OP, HoLEP was associated with significantly less blood loss, a shorter catheterization time and a shorter hospital stay, but a longer operating time. HoLEP and OP were similar in terms of urethral stricture, stress incontinence, transfusion requirement and the rate of reintervention.
CONCLUSIONHoLEP and OP have similar therapeutic effects in the management of large volume benign prostatic hyperplasia. Although with a longer operating time and less resected tissue, HoLEP causes less blood loss and requires a shorter catheterization time and a shorter hospital stay. HoLEP has a comparable safety to OP in terms of the adverse events.
